Home »
Academic Articles »
C »
Synergistic effect of mesenchymal stem cell-derived extracellular vesicle and miR-137 alleviates autism-like behaviors by modulating the NF-κB pathway
Synergistic effect of mesenchymal stem cell-derived extracellular vesicle and miR-137 alleviates autism-like behaviors by modulating the NF-κB pathway
Qian Qin
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Zhiyan Shan
(Department of Histology and Embryology, Harbin Medical University)
Lei Xing
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Yutong Jiang
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Mengyue Li
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Linlin Fan
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Xin Zeng
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Xinrui Ma
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Danyang Zheng
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Han Wang
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Hui Wang
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Hao Liu
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Shengjun Liang
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Lijie Wu
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Shuang Liang
(Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University)
Journal: Journal of Translational Medicine
•
• BMC
• ISSN: 1479-5876
Abstract
Abstract Autism spectrum disorder (ASD) is a multifaceted neurodevelopmental disorder predominant in childhood. Despite existing treatments, the benefits are still limited. This study explored the effectiveness of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) loaded with miR-137 in enhancing autism-like behaviors and mitigating neuroinflammation. Utilizing BTBR mice as an autism model, the study demonstrated that intranasal administration of MSC-miR137-EVs ameliorates autism-like behaviors and inhibits pro-inflammatory factors via the TLR4/NF-κB pathway. In vitro evaluation of LPS-activated BV2 cells revealed that MSC-miR137-EVs target the TLR4/NF-κB pathway through miR-137 inhibits proinflammatory M1 microglia. Moreover, bioinformatics analysis identified that MSC-EVs are rich in miR-146a-5p, which targets the TRAF6/NF-κB signaling pathway. In summary, the findings suggest that the integration of MSC-EVs with miR-137 may be a promising therapeutic strategy for ASD, which is worthy of clinical adoption.
Qian Qin, Zhiyan Shan, Lei Xing, et al. (2024). "Synergistic effect of mesenchymal stem cell-derived extracellular vesicle and miR-137 alleviates autism-like behaviors by modulating the NF-κB pathway". Journal of Translational Medicine. https://doi.org/10.1186/s12967-024-05257-w